WallStreetZenWallStreetZen

NASDAQ: PPBT
Purple Biotech Ltd Stock

$0.67+0.06 (+9.84%)
Updated Mar 28, 2024
PPBT Price
$0.67
Fair Value Price
$0.57
Market Cap
$13.29M
52 Week Low
$0.53
52 Week High
$2.16
P/E
N/A
P/B
0.39x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$19.88M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.29
Operating Cash Flow
-$20M
Beta
0.84
Next Earnings
May 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

PPBT Overview

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer; and NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and squamous cell carcinoma of the head and neck cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel.

Zen Score

–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PPBT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PPBT ($0.67) is overvalued by 16.67% relative to our estimate of its Fair Value price of $0.57 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
PPBT ($0.67) is not significantly undervalued (16.67%) relative to our estimate of its Fair Value price of $0.57 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PPBT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more PPBT due diligence checks available for Premium users.

Be the first to know about important PPBT news, forecast changes, insider trades & much more!

PPBT News

Valuation

PPBT fair value

Fair Value of PPBT stock based on Discounted Cash Flow (DCF)
Price
$0.67
Fair Value
$0.57
Overvalued by
16.67%
PPBT ($0.67) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PPBT ($0.67) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation

PPBT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
0x
Industry
14.26x
Market
44.51x

PPBT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.39x
Industry
6.21x
PPBT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PPBT's financial health

Profit margin

Revenue
$0.0
Net Income
$4.8M
Profit Margin
0%
PPBT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$44.3M
Liabilities
$10.0M
Debt to equity
0.29
PPBT's short-term assets ($15.79M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PPBT's short-term assets ($15.79M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PPBT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PPBT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.0M
Investing
$74.0k
Financing
$4.2M
PPBT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PPBT vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
PPBT$13.29M+9.66%N/A0.39x
EDSA$13.30M-5.80%-1.59x2.27x
MBRX$13.16M+6.68%-0.39x0.50x
DOMH$13.10M-2.00%-0.55x0.22x
ERNA$12.98M+7.14%-0.59x5.81x

Purple Biotech Stock FAQ

What is Purple Biotech's quote symbol?

(NASDAQ: PPBT) Purple Biotech trades on the NASDAQ under the ticker symbol PPBT. Purple Biotech stock quotes can also be displayed as NASDAQ: PPBT.

If you're new to stock investing, here's how to buy Purple Biotech stock.

What is the 52 week high and low for Purple Biotech (NASDAQ: PPBT)?

(NASDAQ: PPBT) Purple Biotech's 52-week high was $2.16, and its 52-week low was $0.53. It is currently -68.98% from its 52-week high and 25.7% from its 52-week low.

How much is Purple Biotech stock worth today?

(NASDAQ: PPBT) Purple Biotech currently has 198,386,080 outstanding shares. With Purple Biotech stock trading at $0.67 per share, the total value of Purple Biotech stock (market capitalization) is $13.29M.

Purple Biotech stock was originally listed at a price of $31.90 in Nov 20, 2015. If you had invested in Purple Biotech stock at $31.90, your return over the last 8 years would have been -97.9%, for an annualized return of -38.3% (not including any dividends or dividend reinvestments).

How much is Purple Biotech's stock price per share?

(NASDAQ: PPBT) Purple Biotech stock price per share is $0.67 today (as of Mar 28, 2024).

What is Purple Biotech's Market Cap?

(NASDAQ: PPBT) Purple Biotech's market cap is $13.29M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Purple Biotech's market cap is calculated by multiplying PPBT's current stock price of $0.67 by PPBT's total outstanding shares of 198,386,080.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.